| Q42566054 | (5Z)-carbacyclin discriminates between prostacyclin-receptors coupled to adenylate cyclase in vascular smooth muscle and platelets |
| Q40204869 | Antithrombotic assessment and clinical potential of prostacyclin analogues. |
| Q41884851 | Characterization of the PGE2 receptor subtype in bovine chondrocytes in culture |
| Q39739043 | Current issues in thrombosis prevention with antiplatelet drugs |
| Q70347430 | Cyclooxygenase inhibition reduces placental transfer: reversal by carbacyclin |
| Q35574131 | Cyclooxygenase-2 modulates cellular growth and promotes tumorigenesis. |
| Q36097438 | Desensitization of prostacyclin receptors in a neuronal hybrid cell line |
| Q41262139 | Effect of prostanoids on renin release from rabbit afferent arterioles with and without macula densa |
| Q42240401 | Effects of SQ 27,427, a thromboxane A2 receptor antagonist, in the human platelet and isolated smooth muscle |
| Q37393089 | Hemostatic mechanisms, independent of platelet aggregation, arrest gastric mucosal bleeding |
| Q73026236 | Inhibition of GABA-gated chloride channels in brain by the arachidonic acid metabolite, thromboxane A2 |
| Q35876629 | Inhibition of inositol 1,4,5-trisphosphate-induced Ca2+ release by cAMP-dependent protein kinase in a living cell |
| Q71448562 | Inhibition of platelet aggregation and reversal of vasopressin-induced ECG changes by a carboprostacyclin analogue, ONO 41483, in primates |
| Q42126640 | Interaction of prostaglandin D2 with prostacyclin, carbacyclin and the hydantoin prostaglandin, BW245C, in guinea-pig platelets |
| Q37084924 | Long-term exposure to PGE2 causes homologous desensitization of receptor-mediated activation of protein kinase A. |
| Q60731511 | Mechano- and chemosensitivity of rat nodose neurones--selective excitatory effects of prostacyclin |
| Q70259759 | Platelet and cardiovascular activity of the hydantoin BW245C, a potent prostaglandin analogue |
| Q41639777 | Platelet prostanoid receptors |
| Q42066683 | Prostacyclin analogs inhibit fibroblast contraction of collagen gels through the cAMP-PKA pathway |
| Q70319609 | Prostacyclin and its Analogues for the Therapy of Thromboembolic Disorders |
| Q72919322 | Some biochemical activities of 10,10-Difluoro-13-dehydroprostacyclin, a chemically stable analog of prostacyclin, in human blood platelets |
| Q42813297 | Stimulation of fat storage by prostacyclin and selective agonists of prostanoid IP receptor during the maturation phase of cultured adipocytes. |
| Q27670895 | Structural Basis for Iloprost as a Dual Peroxisome Proliferator-activated Receptor / Agonist |
| Q72639709 | The antiplatelet and cardiovascular actions of a new carbacyclin derivative (ZK 36 374)--equipotent to PGI2 in vitro |
| Q35886537 | The cardiovascular and platelet actions of 9 beta-methyl carbacyclin (ciprostene), a chemically stable analogue of prostacyclin, in the dog and monkey |
| Q70314047 | The effect of carbacyclin, a prostaglandin analogue, on adenylate cyclase activity in platelet membranes |
| Q48611576 | The use of a prostacyclin analogue, [3H]iloprost, for studying prostacyclin-binding sites on human platelets and neuronal hybrid cells |
| Q33918377 | Thrombosis is reduced by inhibition of COX-1, but unaffected by inhibition of COX-2, in an acute model of platelet activation in the mouse |
| Q59099057 | Vasoconstriction with thromboxane A2 induces ulceration of the gastric mucosa |
| Q35887613 | Vasodilator actions of TRK-100, a new prostaglandin I2 analogue |
| Q54125809 | cGMP inhibits IP3-induced Ca2+ release in intact rat megakaryocytes via cGMP- and cAMP-dependent protein kinases. |